Domenico Girelli: Continuing Commitment to Rare Disease Research
Domenico Girelli, Full Professor of Internal Medicine at the University of Verona, Director of the Department of Medicine at the University of Verona, and Director of the Internal and Emergency Unit at the University Hospital of Verona, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our commitment to research in rare diseases continues…”
Title: Dapagliflozin in Patients With CKD With Fabry Disease
Authors: Yuri Battaglia, Nicola Vitturi, Giacomo Marchi, Federica Baciga, Federica Caccia, Giorgia Gugelmo, Loris Martinetti, Lucia Federica Stefanelli, Sara Torresani, Antonio Pisani, Eleonora Riccio, Pasquale Esposito, Francesca Viazzi, Cristina Chimenti, Francesca Katiana Martino, Livia Lenzini, Annalisa Sechi, Luca Zanoli, Domenico Girelli, Gian Paolo Fadini, Gianni Carraro
Read the Full Article on Science Direct․
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 20, 2026, 15:49David Smadja: Exploring Endothelial Biology and Hemostasis for Innovation in Patient Care
-
Feb 20, 2026, 15:08Maria Cherska: Insights from EAS 2025 on Detection and Long-Term Management of FH
-
Feb 20, 2026, 14:58Maxime Dely: Platelet Agitation Strengthens Quality and Confidence in Transfusion Medicine
-
Feb 20, 2026, 14:26Wolfgang Miesbach: Individualized Hemostasis Care for Gender-Diverse Patients
-
Feb 20, 2026, 14:20Yves Bikorimana: Before Wash vs After Wash in Blood Grouping
-
Feb 20, 2026, 14:17Building Long-Term Hemophilia Care in Kyrgyzstan Beyond Treatment – WFH
-
Feb 20, 2026, 13:45Danny Hsu: Can We Prevent VTE Without Increasing Bleeding Risk?
-
Feb 20, 2026, 10:26Eithne Sexton: Our Interactive Dashboards for Future Stroke Projections at SPHeRE Conference
-
Feb 20, 2026, 10:06Rémi Bonjean: The 1st VHHs Against Active Rap1 to Monitor Platelet Activation